These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 21118496

  • 21. QKI-5 regulates the alternative splicing of cytoskeletal gene ADD3 in lung cancer.
    Wang JZ, Fu X, Fang Z, Liu H, Zong FY, Zhu H, Yu YF, Zhang XY, Wang SF, Huang Y, Hui J.
    J Mol Cell Biol; 2021 Aug 18; 13(5):347-360. PubMed ID: 33196842
    [Abstract] [Full Text] [Related]

  • 22. Implementation of exon arrays: alternative splicing during T-cell proliferation as determined by whole genome analysis.
    Whistler T, Chiang CF, Lonergan W, Hollier M, Unger ER.
    BMC Genomics; 2010 Sep 14; 11():496. PubMed ID: 20840771
    [Abstract] [Full Text] [Related]

  • 23. Genome-wide analysis of differentially expressed genes and splicing isoforms in clear cell renal cell carcinoma.
    Valletti A, Gigante M, Palumbo O, Carella M, Divella C, Sbisà E, Tullo A, Picardi E, D'Erchia AM, Battaglia M, Gesualdo L, Pesole G, Ranieri E.
    PLoS One; 2013 Sep 14; 8(10):e78452. PubMed ID: 24194935
    [Abstract] [Full Text] [Related]

  • 24. Identification and classification of differentially expressed genes in non-small cell lung cancer by expression profiling on a global human 59.620-element oligonucleotide array.
    Hofmann HS, Bartling B, Simm A, Murray R, Aziz N, Hansen G, Silber RE, Burdach S.
    Oncol Rep; 2006 Sep 14; 16(3):587-95. PubMed ID: 16865260
    [Abstract] [Full Text] [Related]

  • 25. Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.
    Renshaw J, Orr RM, Walton MI, Te Poele R, Williams RD, Wancewicz EV, Monia BP, Workman P, Pritchard-Jones K.
    Mol Cancer Ther; 2004 Nov 14; 3(11):1467-84. PubMed ID: 15542786
    [Abstract] [Full Text] [Related]

  • 26. Novel splicing variants of recepteur d'origine nantais (RON) tyrosine kinase involving exons 15-19 in lung cancer.
    Krishnaswamy S, Mohammed AK, Amer OE, Tripathi G, Alokail MS, Al-Daghri NM.
    Lung Cancer; 2016 Feb 14; 92():41-6. PubMed ID: 26775595
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Alternative splicing in colon, bladder, and prostate cancer identified by exon array analysis.
    Thorsen K, Sørensen KD, Brems-Eskildsen AS, Modin C, Gaustadnes M, Hein AM, Kruhøffer M, Laurberg S, Borre M, Wang K, Brunak S, Krainer AR, Tørring N, Dyrskjøt L, Andersen CL, Orntoft TF.
    Mol Cell Proteomics; 2008 Jul 14; 7(7):1214-24. PubMed ID: 18353764
    [Abstract] [Full Text] [Related]

  • 29. High resolution analysis of the human transcriptome: detection of extensive alternative splicing independent of transcriptional activity.
    Zhou W, Calciano MA, Jordan H, Brenner M, Johnson S, Wu D, Lei L, Pallares D, Beurdeley P, Rouet F, Gill PS, Bracco L, Soucaille C, Einstein R.
    BMC Genet; 2009 Oct 05; 10():63. PubMed ID: 19804644
    [Abstract] [Full Text] [Related]

  • 30. Exon-level microarray analyses identify alternative splicing programs in breast cancer.
    Lapuk A, Marr H, Jakkula L, Pedro H, Bhattacharya S, Purdom E, Hu Z, Simpson K, Pachter L, Durinck S, Wang N, Parvin B, Fontenay G, Speed T, Garbe J, Stampfer M, Bayandorian H, Dorton S, Clark TA, Schweitzer A, Wyrobek A, Feiler H, Spellman P, Conboy J, Gray JW.
    Mol Cancer Res; 2010 Jul 05; 8(7):961-74. PubMed ID: 20605923
    [Abstract] [Full Text] [Related]

  • 31. Prediction of alternatively skipped exons and splicing enhancers from exon junction arrays.
    Kechris K, Yang YH, Yeh RF.
    BMC Genomics; 2008 Nov 20; 9():551. PubMed ID: 19021909
    [Abstract] [Full Text] [Related]

  • 32. A cross-platform comparison of genome-wide expression changes of laser microdissected lung tissue of C-Raf transgenic mice using 3'IVT and exon array.
    Londhe KB, Borlak J.
    PLoS One; 2012 Nov 20; 7(7):e40778. PubMed ID: 22815814
    [Abstract] [Full Text] [Related]

  • 33. Gene expression and isoform variation analysis using Affymetrix Exon Arrays.
    Bemmo A, Benovoy D, Kwan T, Gaffney DJ, Jensen RV, Majewski J.
    BMC Genomics; 2008 Nov 07; 9():529. PubMed ID: 18990248
    [Abstract] [Full Text] [Related]

  • 34. A large-scale analysis of alternative splicing reveals a key role of QKI in lung cancer.
    de Miguel FJ, Pajares MJ, Martínez-Terroba E, Ajona D, Morales X, Sharma RD, Pardo FJ, Rouzaut A, Rubio A, Montuenga LM, Pio R.
    Mol Oncol; 2016 Nov 07; 10(9):1437-1449. PubMed ID: 27555542
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Genome-Wide Analysis of Prognostic Alternative Splicing Signature and Splicing Factors in Lung Adenocarcinoma.
    Chang YS, Tu SJ, Chiang HS, Yen JC, Lee YT, Fang HY, Chang JG.
    Genes (Basel); 2020 Oct 31; 11(11):. PubMed ID: 33142748
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. A systematic comparison and evaluation of high density exon arrays and RNA-seq technology used to unravel the peripheral blood transcriptome of sickle cell disease.
    Raghavachari N, Barb J, Yang Y, Liu P, Woodhouse K, Levy D, O'Donnell CJ, Munson PJ, Kato GJ.
    BMC Med Genomics; 2012 Jun 29; 5():28. PubMed ID: 22747986
    [Abstract] [Full Text] [Related]

  • 40. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
    Dutertre M, Lacroix-Triki M, Driouch K, de la Grange P, Gratadou L, Beck S, Millevoi S, Tazi J, Lidereau R, Vagner S, Auboeuf D.
    Cancer Res; 2010 Feb 01; 70(3):896-905. PubMed ID: 20103641
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.